Skip to main content

Georgina Arrambide García

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Georgina Arrambide García

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Profiling of patients with highly active multiple sclerosis and assessment of highly efficacious treatment effects on the evolution of their disease

IP: Georgina Arrambide García
Collaborators: Miriam Izquierdo Sans
Funding agency: ECTRIMS
Funding: 55000
Reference: ECTRIMS/CLINICAL-TRAININGFELLOWSHIP/2023/ARRAMBIDE
Duration: 06/10/2023 - 05/10/2024

Caracterización de pacientes con esclerosis múltiple muy activa y evaluación del efecto de tratamientos de alta efectividad en la evolución de su enfermedad.

IP: Georgina Arrambide García
Collaborators: Jordi Rio Izquierdo, Caracterización de pacientes con esclerosis múltiple muy activa y evaluación del efecto de tratamientos de alta efectividad en l, Joaquin Castillo Justribo, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 169400
Reference: PI22/01570
Duration: 01/01/2023 - 31/12/2025

Estudio de neurofilamentos de cadena ligera como factores pronósticos en esclerosis múltiple

IP: Georgina Arrambide García
Collaborators: Miriam Izquierdo Sans
Funding agency: ECTRIMS
Funding: 55000
Reference: ECTRIMS/MSCTF/FERNANDEZ/2022
Duration: 01/10/2022 - 30/09/2023

Niveles en suero de neurofilamentos de cadena ligera como marcador pronóstico de evolución de la enfermedad y de respuesta al tratamiento en esclerosis múltiple

IP: Georgina Arrambide García
Collaborators: Jordi Rio Izquierdo, Rosalia Horno Ocaña, Cristina Auger Acosta, Joaquin Castillo Justribo, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: PI19/01590
Duration: 01/01/2020 - 30/06/2024

Related news

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

The Barcelona Risk Score is a flexible, generalisable clinical tool that will play a key role in selecting the most effective treatment for each person with multiple sclerosis

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Related professionals

Javier Domeño Baztán

Javier Domeño Baztán

Research technician
Clinical Neuroimmunology
Read more
Jesús Quintero Bernabeu

Jesús Quintero Bernabeu

Main researcher
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Yassin Belahnech Pujol

Yassin Belahnech Pujol

Main researcher
Cardiovascular Diseases
Read more
Alex  Mur  Espinosa

Alex Mur Espinosa

Predoctoral researcher
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.